Rizvi Meher, Azam Mohd, Sultan Asfia, Shukla Indu, Malik Abida, Ajmal Masihur Reman, Khan Fatima, Sami Hiba
Department of Microbiology, Jawaharlal Nehru Medical College and Hospital, Aligarh Muslim University (AMU), Aligarh, Uttar Pradesh, India.
Indian J Pathol Microbiol. 2014 Oct-Dec;57(4):537-41. doi: 10.4103/0377-4929.142643.
Etiology of nearly 30% cases of chronic viral hepatitis remains undetected. Occult HBV infection (OBI) has emerged as an important clinical entity in this scenario. Apart from prevalence and clinical outcome of OBI patients genotype was determined in northern region of India.
A total of 847 patients with chronic liver disease (CLD) were screened for common viral etiologies and others serological markers of HBV. Amplification of surface, precore and polymerase genes of HBV was performed in patients negative for other etiologies. Genotyping and sequencing of the precore region was performed for OBI cases.
Twenty-nine (7.61%) cases of OBI were identifiedof which 9 had chronic liver disease (CHD), 11 liver cirrhosis (LC) and 9 hepatocellular carcinoma (HCC). Majority of OBI cases were detected by amplification of surface gene 26 (89.6%), followed by pre-core gene 12 (41.3%). Their liver functions tests were significantly deranged in comparison to overt HBV cases. IgG anti HBc was present in 8 (27.6%) OBI cases. Mutation was observed in 8 (32%) in pre-core region at nt. 1896 of overt HBV cases. Genotype D was the predominant genotype.
OBI in our study was characterized by predominance of genotype D and more severe clinical and biochemical profile in comparison to overt HBV. IgG anti HBc positivity could be utilized as a marker of OBI. We recommend use of sensitive nested PCR for diagnosis of OBI, amplifying at least surface and precore gene.
近30%的慢性病毒性肝炎病例病因仍未明确。隐匿性乙型肝炎病毒感染(OBI)在这种情况下已成为一个重要的临床实体。除了OBI患者的患病率和临床结局外,还在印度北部地区确定了其基因型。
对847例慢性肝病(CLD)患者进行常见病毒病因及其他乙肝血清学标志物筛查。对其他病因检测呈阴性的患者进行乙肝表面、前核心和聚合酶基因扩增。对OBI病例进行前核心区基因分型和测序。
共鉴定出29例(7.61%)OBI病例,其中9例患有慢性肝病(CHD),11例肝硬化(LC),9例肝细胞癌(HCC)。大多数OBI病例通过表面基因扩增检测到26例(89.6%),其次是前核心基因12例(41.3%)。与显性乙肝病例相比,他们的肝功能检查明显紊乱。8例(27.6%)OBI病例中存在IgG抗HBc。在显性乙肝病例的前核心区第1896位核苷酸处,8例(32%)观察到突变。D基因型是主要基因型。
我们研究中的OBI特点是D基因型占主导,与显性乙肝相比,临床和生化特征更严重。IgG抗HBc阳性可作为OBI的标志物。我们建议使用敏感的巢式PCR诊断OBI,至少扩增表面和前核心基因。